Skip to main content

Table 5 Disease versus patient-oriented outcomes

From: Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review

Disease-oriented outcomes Patient-oriented outcomes
Total cholesterol, LDL, HDL Rate of hospitalization
HbA1c Length of stay
Haematocrit, Tsat, ferritin, haemoglobin Health-related quality of life
SBP, DBP Medication-related knowledge
Phosphorus, calcium-phosphorus product Renal quality of life
Drug dosages (e.g., EPO dosage or ferrous dosage) Patient satisfaction survey